Pharmaceuticals

Male Infertility Market Forecast 2026: Where the Industry Is Headed

March 2, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the male infertility market from 2026–2035 with trusted insights from The Business Research Company

By how much is the Male Infertility Market expected to grow between 2026 and 2030?

The market for male infertility solutions has experienced substantial growth in recent years. It is anticipated to expand from $4.33 billion in 2025 to $4.57 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 5.6%. This historical expansion can be ascribed to factors such as a global decline in sperm quality, a higher incidence of infertility linked to lifestyle, the proliferation of fertility clinics, increasing acceptance of ART procedures, and advancements in semen analysis methods.

The male infertility market is projected to experience substantial growth in the coming years. It is anticipated to expand to $5.76 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.0%. This growth during the forecast period can be attributed to several factors, including an increase in infertility rates due to environmental influences, a rising demand for IVF and ICSI procedures, advancements in fertility diagnostic technologies, greater awareness of male reproductive health, and improved access to fertility treatments in developing markets. Key trends expected over this period involve the increasing adoption of assisted reproductive technologies, the expanded use of sophisticated sperm diagnostic tests, a heightened focus on hormonal and targeted drug therapies, the broadening of microsurgical treatments for male infertility, and enhanced awareness leading to earlier diagnosis of male infertility.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24286&type=smp

Which Drivers Are Influencing Market Acceleration In The Male Infertility Market?

Elevated stress levels are projected to boost the expansion of the male infertility market in the future. Stress refers to the degree of emotional, physical, or mental tension experienced due to demanding circumstances or pressures. This rise in stress is linked to growing work demands, where constant pressure and elevated expectations lead to exhaustion and negatively impact mental well-being and work-life equilibrium. Heightened stress can disrupt hormonal equilibrium, diminish sperm quality, and compromise sexual performance, thereby contributing to male infertility. Persistent stress upsets cortisol and testosterone levels, fostering an increase in infertility occurrences. As an illustration, data from May 2024 by the American Psychiatric Association, a US-based professional body for psychologists, revealed that 43% of adults in the US reported increased anxiety in 2024, up from 37% in 2023 and 32% in 2022, signaling a steady rise in anxiety. Consequently, the escalation of stress levels is fueling the expansion of the male infertility market.

What Leading Segments Are Studied In The Male Infertility Market?

The male infertility market covered in this report is segmented –

1) By Treatment Type: Medication, Surgery, Assisted Reproductive Technology

2) By Test Type: Sperm Agglutination, Deoxyribonucleic Acid Fragmentation Technique, Oxidative Stress Analysis, Computer Assisted Semen Analysis, Sperm Penetration Assay, Other Test Types

3) By Distribution Channel: Hospitals Pharmacies, Pharmacies And Drug Stores, Online Pharmacies

4) By End-User: Hospitals And Clinics, Fertility Centers, Research Institutes, Other End-Users

Subsegments:

1) By Medication: Hormone Treatments, Gonadotropins, Antibiotics, Antiestrogens, Dopamine Agonists

2) By Surgery: Varicocelectomy, Vasovasostomy, Epididymovasostomy, Transurethral Resection of the Ejaculatory Duct (TURED), Sperm Retrieval Procedures

3) By Assisted Reproductive Technology (ART): In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), Intrauterine Insemination (IUI), Sperm Donation, Cryopreservation Of Sperm

What Upcoming Trends Are Likely To Define The Future Path Of The Male Infertility Market?

Leading companies in the male infertility market are emphasizing strategic partnership approaches to enhance access to advanced fertility treatments across global markets. Strategic partnerships involve collaborations between organizations that combine their resources and expertise to achieve mutual objectives. Such alliances facilitate innovation, expand market presence, and boost research and development efforts. For instance, in June 2024, Ferring Pharmaceuticals, a Switzerland-based pharmaceutical company, collaborated with Posterity Health, a US-based male fertility clinic, to unveil a male fertility program on Ferring’s Fertility Out Loud platform designed to inform men about their fertility. This initiative furnishes men with a confidential online assessment and educational materials developed by reproductive urologists, helping them grasp their fertility status and lessen the stigma associated with male infertility, which accounts for up to 50% of infertility cases. The program seeks to empower men to take prompt action, potentially improving a couple’s journey to parenthood by addressing male fertility concerns earlier and more conveniently through digital tools and telehealth.

Which Key Players Are Driving Competition In The Male Infertility Market?

Major companies operating in the male infertility market are Novartis AG, Amgen Inc., Teva Pharmaceutical Industries Ltd., Intas Pharmaceuticals Ltd., NYU Langone Hospitals, Sun Pharmaceutical Industries Ltd., Cipla Limited, Ferring Pharmaceuticals, Fortis Healthcare, Vitrolife, Max Healthcare, CinnaGen Co., Aytu BioScience Inc., Zydus Hospitals and Healthcare Research Private Limited, Apricus Biosciences Inc., SCSA Diagnostics Inc., Andrology Solutions, Halotech DNA, Indira IVF, Conduit Pharmaceuticals, Shree IVF Clinics

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/male-infertility-global-market-report

Which Region Is Projected To Lead The Male Infertility Market During The Forecast Period?

North America was the largest region in the male infertility market in 2025. The regions covered in the male infertility market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Male Infertility Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24286&type=smp

Browse Through More Reports Similar to the Global Male Infertility Market 2026, By The Business Research Company

Male Fertility Market Report 2026

https://www.thebusinessresearchcompany.com/report/male-fertility-global-market-report

Infertility Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/infertility-treatment-global-market-report

Fertility Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/fertility-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795